Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells
Molecules · 2024
DOI: 10.3390/molecules29091907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Si Yu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Brain Science and Health Translational Medicine Research Center in Tropical Environment of Hainan Province, Hainan Medical Universi…. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Carbon, Citric Acid, Polyethyleneimine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Province Science and Technology Special Fund of China, Hainan Provincial Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
(1)
Background
Alzheimer’s disease (AD) is characterized by β-amyloid (Aβ) peptide accumulation and mitochondrial dysfunction during the early stage of disease. PINK1 regulates the balance between mitochondrial homeostasis and bioenergy supply and demand via the PINK1/Parkin pathway, Na+/Ca2+ exchange, and other pathways. (2)
Methods
In this study, we synthesized positively charged carbon dots (CA-PEI CDs) using citric acid (CA) and polyethyleneimine (PEI) and used them as vectors to express PINK1 genes in the APP/PS1-N2a cell line to determine mitochondrial function, electron transport chain (ETC) activity, and ATP-related metabolomics. (3)
Results
Our findings showed that the CA-PEI CDs exhibit the characteristics of photoluminescence, low toxicity, and concentrated DNA. They are ideal biological carriers for gene delivery. PINK1 overexpression significantly increased the mitochondrial membrane potential in APP/PS1-N2a cells and reduced reactive-oxygen-species generation and Aβ1-40 and Aβ1-42 levels. An increase in the activity of NADH ubiquinone oxidoreductase (complex I, CI) and cytochrome C oxidase (complex IV, CIV) induces the oxidative phosphorylation of mitochondria, increasing ATP generation. (4)
Conclusions
These findings indicate that the PINK gene can alleviate AD by increasing bioenergetic metabolism, reducing Aβ1-40 and Aβ1-42, and increasing ATP production.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Brain Science and Health Translational Medicine Research Center in Tropical Environment of Hainan Province, Hainan Medical University, Haikou 571199, China.
- Clinical Medical College, Gannan Medical University, Ganzhou 341000, China.
- Affiliated Haikou Hospital of Xiangya Medical College, Central South University, Haikou 571199, China.
- Hainan Provincial Key Laboratory of Carcinogenesis and Intervention, Hainan Medical University, Haikou 571199, China.
ORCID-Profile: Haiying Zhang
Förderung
- Hainan Province Science and Technology Special Fund of China
- Hainan Provincial Natural Science Foundation of China
- National Natural Science Foundation of China
- Innovative Research Projects for Graduate Students in Hainan Province, China
Zitieren
APA
Yu, S., Guo, F., Luo, Y., Zhang, X., Wang, C., Liu, Y., & Zhang, H. (2024). Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells. Molecules. https://doi.org/10.3390/molecules29091907
Vancouver
Yu S, Guo F, Luo Y, Zhang X, Wang C, Liu Y, et al. Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells. Molecules. 2024. doi:10.3390/molecules29091907
BibTeX
@article{Yu2024,
author = {Yu, Si and Guo, Feng and Luo, Yuzhen and Zhang, Xingfang and Wang, Chenyu and Liu, Yiheng and Zhang, Haiying},
title = {Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29091907}
}
EUVIMED